Publicaciones en colaboración con investigadores/as de Hospital Royo Villanova (24)

2024

  1. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  2. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  3. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  4. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

2023

  1. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

  2. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  3. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  4. Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry

    Internal and emergency medicine, Vol. 18, Núm. 3, pp. 907-915

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)

    Endocrine Connections, Vol. 11, Núm. 6

  3. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

    JAMA Network Open, Vol. 5, Núm. 1

  4. Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: results from the SEMI-COVID-19 registry

    Medicina Clinica, Vol. 159, Núm. 5, pp. 214-223

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  3. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  4. Spanish and Portuguese Societies of Internal Medicine consensus guideline about best practice in end-of-life care

    Revista Clinica Espanola, Vol. 221, Núm. 1, pp. 33-44

2020

  1. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  2. Palliative Sedation in Patients Hospitalized in Internal Medicine Departments

    Journal of Pain and Symptom Management, Vol. 59, Núm. 2, pp. 302-309

2018

  1. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

2017

  1. Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369